DAWN EBITDA Growth
Day One Biopharmaceuticals Inc · EBITDA Growth
DAWN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported61.94%period ending
DAWN Quarterly EBITDA YoY % (-712.00% → 61.94%)
Year-over-year change
High-resolution chart · PNG
DAWN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 61.9364% | |
| -150.9254% | |
| -1,099.7548% | |
| 43.6529% | |
| -7.486% | |
| 180.1307% | |
| 94.6538% | |
| -47.2579% | |
| -36.2619% | |
| -22.3784% | |
| -25.7549% | |
| -52.7551% | |
| -82.3658% | |
| -96.153% | |
| -136.0835% | |
| -72.6882% | |
| 38.3986% | |
| -406.5751% | |
| -555.2061% | |
| -712% |